SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641489-23-000008
Filing Date
2023-03-06
Accepted
2023-03-06 17:30:33
Documents
102
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vtvt-20221231.htm   iXBRL 10-K 2235277
2 EX-10.36 vtvt-20221231xexx1036g42_d.htm EX-10.36 39306
3 EX-10.37 vtvt-20221231xexx1037varia.htm EX-10.37 44770
4 EX-21.1 vtvt-20221231xexx211subsid.htm EX-21.1 2942
5 EX-23.1 vtvt-20221231xex231eyconse.htm EX-23.1 6086
6 EX-31.1 vtvt-20221231xexx311.htm EX-31.1 10227
7 EX-31.2 vtvt-20221231xexx312.htm EX-31.2 10103
8 EX-32.1 vtvt-20221231xexx321.htm EX-32.1 5067
9 EX-32.2 vtvt-20221231xexx322.htm EX-32.2 4951
15 vtvt-20221231_g1.jpg GRAPHIC 123143
  Complete submission text file 0001641489-23-000008.txt   10442013

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20221231.xsd EX-101.SCH 82529
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20221231_cal.xml EX-101.CAL 74972
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20221231_def.xml EX-101.DEF 454237
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20221231_lab.xml EX-101.LAB 842283
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20221231_pre.xml EX-101.PRE 587406
96 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20221231_htm.xml XML 1478684
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37524 | Film No.: 23710103
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences